The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Combination Antifungal Therapy for Invasive Aspergillosis
Open accessAbstract
BACKGROUND: Aspergillosis therapy with amphotericin, azoles, or echinocandins is associated with substantial mortality, ranging from 30% to 80%, depending on the stage of infection and the host's underlying disease. The results of in vitro studies and animal models suggest that combination therapy with azoles and echinocandins may have additive activity against Aspergillus species. METHODS: We evaluated the outcomes of patients with aspergillosis who experienced failure of initial therapy with amphotericin B formulations and received either voriconazole (n=31) or a combination of voriconazole and caspofungin (n=16) for salvage therapy. RESULTS: The combination of voriconazole and caspofungin was associated with improved 3-month survival rate, compared with voriconazole alone (hazard ratio [HR], 0.42; 95% confidence interval [CI], 0.17-1.1; P=.048). In multivariable models, salvage therapy with the combination of voriconazole and caspofungin was associated with reduced mortality, compared with therapy with voriconazole (HR, 0.28; 95% CI, 0.28-0.92; P=.011), independent of other prognostic variables (e.g., receipt of transplant and type of conditioning therapy). The probability of death due to aspergillosis was lowest in patients who received the combination regimen. CONCLUSIONS: Randomized trials are warranted to determine whether this combination should be used as primary therapy for aspergillosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Self-citationAscioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,448
Self-citationAspergillosis Case-Fatality Rate: Systematic Review of the Literature
Lin, S.-J., Schranz, J., & Teutsch, S. M. (2001) · Clinical Infectious Diseases · doi:10.1086/318483 · Cited by 1,409
McSweeney, P. A., Niederwieser, D., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,389
Marr, K. A., Carter, R. A., Boeckh, M., Martin, P., & Corey, L. (2002) · Blood · doi:10.1182/blood-2002-05-1496 · Cited by 957
Self-citationEfficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
Denning, D. W., Ribaud, P., Milpied, N., Caillot, D., Herbrecht, R., Thiel, E., Haas, A., Ruhnke, M., & Lode, H. (2002) · Clinical Infectious Diseases · doi:10.1086/324620 · Cited by 844
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., WINGARD, J. R., DUPONT, B., RINALDI, M. G., STEVENS, D. A., & Graybill, J. R. (2000) · Medicine · doi:10.1097/00005792-200007000-00006 · Cited by 791
Marr, K. A., Seidel, K., Slavin, M. A., Bowden, R. A., Schoch, H. G., Flowers, M. E. D., Corey, L., & Boeckh, M. (2000) · Blood · doi:10.1182/blood.v96.6.2055 · Cited by 511
Self-citationRex, J. H., Pappas, P. G., Karchmer, A. W., Sobel, J., Edwards, J. E., Hadley, S., Brass, C., Vazquez, J. A., Chapman, S. W., Horowitz, H. W., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374850 · Cited by 495
Fukuda, T., Boeckh, M., Carter, R. A., Sandmaier, B. M., Maris, M. B., Maloney, D. G., Martin, P. J., Storb, R. F., & Marr, K. A. (2003) · Blood · doi:10.1182/blood-2003-02-0456 · Cited by 465
Self-citationPharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation Regimens
Purkins, L., Wood, N., Ghahramani, P., Greenhalgh, K., Allen, M. J., & Kleinermans, D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2546-2553.2002 · Cited by 415
Clift, R., Buckner, C., Thomas, E., Bensinger, W., Bowden, R., Bryant, E., Deeg, H., Doney, K., Fisher, L., & Hansen, J. (1994) · Blood · doi:10.1182/blood.v84.6.2036.2036 · Cited by 358
Kontoyiannis, D. P., Hachem, R., Lewis, R. E., Rivero, G. A., Torres, H. A., Thornby, J., Champlin, R., Kantarjian, H., Bodey, G. P., & Raad, I. I. (2003) · Cancer · doi:10.1002/cncr.11479 · Cited by 287
Kirkpatrick, W. R., Perea, S., Coco, B. J., & Patterson, T. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2564-2568.2002 · Cited by 282
In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp
Arikan, S., Lozano-Chiu, M., Paetznick, V., & Rex, J. H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.245-247.2002 · Cited by 280
Espinel-Ingroff, A., Boyle, K., & Sheehan, D. J. (2001) · Mycopathologia · doi:10.1023/a:1010954803886 · Cited by 251
Junghanss, C., Marr, K. A., Carter, R. A., Sandmaier, B. M., Maris, M. B., Maloney, D. G., Chauncey, T., McSweeney, P. A., & Storb, R. (2002) · Biology of Blood and Marrow Transplantation · doi:10.1053/bbmt.2002.v8.pm12374456 · Cited by 251
Self-citationGroup sequential designs using a family of type I error probability spending functions
Hwang, I. K., Shih, W. J., & De Cani, J. S. (1990) · Statistics in Medicine · doi:10.1002/sim.4780091207 · Cited by 248
Ribaud, P., Chastang, C., Latgé, J., Baffroy‐Lafitte, L., Parquet, N., Espéton, A. D. H., Sélimi, F., Rocha, V., Derouin, F., Socié, G., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515116 · Cited by 236
Petraitis, V., Petraitiene, R., Sarafandi, A. A., Kelaher, A. M., Lyman, C. A., Casler, H. E., Sein, T., Groll, A. H., Bacher, J., Avila, N. A., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/375420 · Cited by 233
Aliff, T. B., Maslak, P. G., Jurcic, J. G., Heaney, M. L., Cathcart, K. N., Sepkowitz, K. A., & Weiss, M. A. (2003) · Cancer · doi:10.1002/cncr.11115 · Cited by 227
Grow, W., Moreb, J., Roque, D., Manion, K., Leather, H., Reddy, V, Khan, S., Finiewicz, K., Nguyen, H., Clancy, C., et al. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703332 · Cited by 192
Perea, S., Gonzalez, G., Fothergill, A. W., Kirkpatrick, W. R., Rinaldi, M. G., & Patterson, T. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3039-3041.2002 · Cited by 186
Infections diagnosed in the first year after pediatric stem cell transplantation
Benjamin, D. K., Miller, W. C., Bayliff, S. L., Martel, L., ALEXANDER, K. A., & Martin, P. L. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200203000-00013 · Cited by 146
Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients
Reichenberger, F., Habicht, J. M., Gratwohl, A. A., & Tamm, M. (2001) · European Respiratory Journal · doi:10.1183/09031936.02.00256102 · Cited by 143
Use of amphotericin B with azole antifungal drugs: what are we doing?
Sugar, A. M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1907 · Cited by 135
Safety and Pharmacokinetics of Coadministered Voriconazole and Anidulafungin
Dowell, J. A., Schranz, J., Baruch, A. M., & Foster, G. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005281234 · Cited by 83
Caspofungin in Combination with Itraconazole for the Treatment of Invasive Aspergillosis in Humans
Rubin, M. A., Carroll, K. C., & Cahill, B. C. (2002) · Clinical Infectious Diseases · doi:10.1086/339755 · Cited by 77
Cesaro, S., Toffolutti, T., Messina, C., Calore, E., Alaggio, R., Cusinato, R., Pillon, M., & Zanesco, L. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00254.x · Cited by 55
Combination Therapy for Invasive Aspergillosis
Viscoli, C. (2004) · Clinical Infectious Diseases · doi:10.1086/423389 · Cited by 48
Combination Therapy for Aspergillosis: Is It Needed, and Which Combination?
Wheat, L. J. (2003) · The Journal of Infectious Diseases · doi:10.1086/375418 · Cited by 24
Combination therapy with caspofungin and amphotericin B lipid complex
Lum, L. R., Turco, T. F., & Leone, J. (2002) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/59.1.80 · Cited by 21
Cited by
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citationWalsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Self-citationUllmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Pulmonary aspergillosis: a clinical review
Kousha, M., Tadi, R., & Soubani, A. O. (2011) · European Respiratory Review · doi:10.1183/09059180.00001011 · Cited by 752
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
Perlroth, J., Choi, B., & Spellberg, B. (2007) · Medical Mycology · doi:10.1080/13693780701218689 · Cited by 738
Metadata
- Authors
- Marr, K. A., Boeckh, M., Carter, R. A., Kim, H. W., & Corey, L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-09-15
- Volume
- 39
- Issue
- 6
- Pages
- 797-802
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2102584901
- Cited by
- 596
- References
- 35
- FWCI
- 37.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.